Medical / Pharmaceuticals
Releases published in the last 30 days. 
Page 1 of 3
- DSV expands Air ThermoDirect network with direct Shanghai connections to global pharma hubs
- 9/4/2026 10:38:38 AM
- DSV is expanding its global Air ThermoDirect network with a new direct connection between Luxembourg and Shanghai Pudong International Airport (PVG), with additional US routes planned.
- WHO validates Bhutan for eliminating dog-transmitted human rabies
- 9/4/2026 7:20:38 AM
- The World Health Organization (WHO) has validated Bhutan’s elimination of dog-transmitted rabies as a public health problem in the country. Bhutan is the first country in the WHO South-East Asia Region to achieve this success.
- Johnson & Johnson to Participate in the Deutsche Bank 2026 Healthcare Summit
- 9/3/2026 11:21:19 AM
- Johnson & Johnson (NYSE: JNJ) will present at the Deutsche Bank 2026 Healthcare Summit on Thursday, September 17 th, 2026. Management will participate in a Fireside Chat at 12:00 p.m.
- AMA, Vaccine Integrity Project unveil independent vaccine evidence review
- 9/3/2026 10:53:19 AM
- The Vaccine Integrity Project, in collaboration with the American Medical Association (AMA), today announced the completion of an independent, vaccine evidence review that assessed the safety and effectiveness of immunizations against influenza, SARS CoV-2 and respiratory syncytial virus (RSV).
- Unisys Research on Trustworthy AI Published in Frontiers in Pharmacology Journal
- 9/2/2026 10:29:17 AM
- Unisys (NYSE: UIS) announces the publication of its peer-reviewed research paper, “From benchmark accuracy to pharmacological credibility: why mechanistic explainability must define the next generation of AI for drug repurposing,” in Frontiers in Pharmacology, a leading journal from Frontiers Media.
- NSF launches three new Science and Technology Centers with $90M investment in transformative research
- 9/1/2026 9:21:23 AM
- The U.S. National Science Foundation is investing $90 million over five years to support three new NSF Science and Technology Centers (NSF STC). These centers will advance American leadership in science and technology, strengthen the nation’s STEM workforce, and accelerate innovation in fields ranging from artificial intelligence and biotechnology to fusion energy and …
- As U.S. Measles Cases Rise and Biological Threats Remain Under Surveillance, Ashish Jha to Headline ConV2X New York
- 8/31/2026 8:00:00 AM
- Against a backdrop of rising U.S. measles cases and continued surveillance of H5 bird flu, Ashish K. Jha, MD, MPH, former White House COVID-19 Response Coordinator and Co-Founder and CEO of BioRadar, will headline the ConV2X Smart Tech Transformation in Healthcare & Life Sciences Executive Summit, taking place October 29–30, 2026, at the Historic GE Building, ILR Conference …
- FedEx Passes Milestone in CEIV Pharma Certifications
- 8/28/2026 7:07:16 PM
- FedEx Corp. (NYSE: FDX) has achieved a major milestone in its healthcare logistics journey, securing 30 IATA CEIV Pharma certifications across its global air hubs and cargo handling facilities.
- Assessment of Culinary Skills Among Adults with Visual Impairment Highlights Gaps Between Ability and Independence
- 8/28/2026 6:47:17 PM
- A recent study in the Journal of Nutrition Education and Behavior (JNEB), published by Elsevier, examined culinary skills and related barriers among adults with visual impairment.
- Second meeting of the IHR Emergency Committee on the epidemic of Ebola Bundibugyo virus disease in the Democratic Republic of the Congo – Meeting report
- 8/28/2026 6:19:04 PM
- The Director-General (DG) of the World Health Organization (WHO) is hereby transmitting the report of the second meeting of the International Health Regulations (2005) ( IHR ) Emergency Committee (Committee) regarding the epidemic of Ebola disease caused by Bundibugyo virus (BVD) in the Democratic Republic of the Congo (DRC), held on Tuesday, 18 August 2026, from 12:00 to …
- Tezspire demonstrates positive Phase III results in eosinophilic esophagitis across both co-primary and all key secondary endpoints
- 8/27/2026 12:46:39 PM
- Positive high-level results from the Phase III CROSSING trial in patients with eosinophilic esophagitis (EoE) showed that AstraZeneca and Amgen’s Tezspire (tezepelumab) demonstrated statistically significant and clinically meaningful improvements across both co-primary and all key secondary endpoints at week 24, which were sustained through week 52 in both doses tested.
- AMA introduces Ethical AI Use in Medicine Series
- 8/27/2026 12:44:09 PM
- The American Medical Association (AMA) today announced the Ethical AI Use in Medicine Series, a new continuing medical education (CME) program that helps physicians safely, effectively and ethically utilize augmented/artificial intelligence (AI) in clinical practice.
- Sony Computer Science Laboratories Develops Origami-Inspired Surgical Robot and Achieves Subretinal Injection in an Animal Model
- 8/26/2026 10:08:22 AM
- Sony Computer Science Laboratories President: Hiroaki Kitano; (hereinafter “Sony CSL”) has developed Origanoid, a compact surgical robotic manipulator inspired by origami structures, through collaborative research with VCCT Inc.
- How to Teach T Cells to Track Cancer Like a Hound Dog
- 8/26/2026 9:50:33 AM
- The immune system is full of T cells that could hunt down and destroy tumors, if they were primed. Now, a UC San Francisco team has invented a way to do this by combining immune cells that are grown in the lab with samples from a patient’s tumor.
- ConV2X Expands Cambridge Executive Summit With New Healthcare, FDA, AI, and Cybersecurity Leaders
- 8/26/2026 8:00:00 AM
- ConV2X today announced a new group of in-person speakers joining its September 24–25 executive summit at The Foundry in Cambridge, Massachusetts, expanding the multidisciplinary dialogue around AI infrastructure, decentralized health, cybersecurity, regulation, clinical implementation and the technologies reshaping healthcare and life sciences.
- Mozambique strengthens regulation of medicines and imported vaccines, boosting health protection
- 8/25/2026 10:57:59 AM
- Mozambique has reached a major milestone in strengthening the regulation of medicines and imported vaccines, with its national regulatory authority recognized by the World Health Organization (WHO) as having a stable, well-functioning and integrated regulatory system.
- Bangladesh: 35% of Rohingya Refugees Face ‘Crisis ’or ‘Emergency’ Hunger as Conditions for Children Worsen
- 8/25/2026 10:52:49 AM
- Conditions in the world’s largest refugee settlement are worsening at an alarming rate after nine years, with 35% of Rohingya refugees in Bangladesh expected to face ‘crisis’ or ‘emergency’ hunger levels this year, putting more children at risk of malnutrition.[1] Nine years after hundreds of thousands of Rohingya fled attacks and violence in Myanmar, an entire …
- AGC and Neusignal Therapeutics Collaborate on the Development of Alzheimer’s Disease Drug Candidate “NTX-083”
- 8/24/2026 12:06:13 PM
- AGC Inc. (Headquarters: Tokyo; President: Yoshinori Hirai; hereinafter “AGC”) highlights its end-to-end support capabilities as a small-molecule pharmaceutical CDMO as demonstrated by its collaboration with Neusignal Therapeutics, Inc.
- Johnson & Johnson Announces New Global Classification System for Surgical Outcomes
- 8/24/2026 10:51:15 AM
- Johnson & Johnson today announced the publication of the DISH Classification System, a new global consensus framework developed and validated through a clinician-led initiative to standardize how surgical site outcomes are measured and reported and help bring greater visibility to underreported surgical site infections and other wound complications.
- WHO and Peking University strengthen collaboration to advance health emergency preparedness
- 8/24/2026 10:49:20 AM
- The World Health Organization (WHO) and Peking University have entered into a two-year project collaboration agreement to strengthen global health emergency preparedness through research, training and innovative analytical approaches.